Suppr超能文献

心力衰竭中克隆性造血的重要性。

Importance of clonal hematopoiesis in heart failure.

机构信息

Berne Cardiovascular Research Center USA; Department of Cardiology USA; Hematovascular Biology Center, University of Virginia, School of Medicine, Charlottesville, VA, 22908 USA.

Berne Cardiovascular Research Center USA; Department of Cardiology USA; Hematovascular Biology Center, University of Virginia, School of Medicine, Charlottesville, VA, 22908 USA.

出版信息

Trends Cardiovasc Med. 2022 May;32(4):198-203. doi: 10.1016/j.tcm.2021.04.005. Epub 2021 Apr 20.

Abstract

Heart failure is prevalent in the elderly population. Inflammatory processes can contribute to the progression of heart failure by altering the balance of tissue healing and pathological remodeling during the injury response. New findings show that aging can alter immune cell phenotypes through the process of clonal hematopoiesis. This condition results from acquired somatic DNA mutations in specific driver genes that give rise to clonal expansions of mutant hematopoietic cells with overactive inflammatory properties. Recent clinical and experimental studies have shown that clonal hematopoiesis is prevalent in heart failure patients and associated with poor prognosis. In this review, we summarize current evidence that associates clonal hematopoiesis with the progression of heart failure. We further describe the mechanistic links between clonal hematopoiesis and the pro-inflammatory responses that can contribute to pathological outcomes in the heart. Finally, we provide perspectives on future research directions in the area of clonal hematopoiesis and heart failure.

摘要

心力衰竭在老年人群中较为普遍。炎症过程可通过改变损伤反应过程中组织修复和病理性重塑之间的平衡,从而促进心力衰竭的进展。新的研究结果表明,衰老可通过克隆性造血过程改变免疫细胞表型。这种情况是由于特定驱动基因获得性体细胞 DNA 突变引起的,导致具有过度活跃炎症特性的突变造血细胞的克隆性扩增。最近的临床和实验研究表明,克隆性造血在心力衰竭患者中较为普遍,并与预后不良相关。在这篇综述中,我们总结了将克隆性造血与心力衰竭进展相关联的现有证据。我们进一步描述了克隆性造血与促炎反应之间的机制联系,这些反应可能导致心脏的病理性结局。最后,我们对克隆性造血和心力衰竭领域的未来研究方向提供了一些观点。

相似文献

1
Importance of clonal hematopoiesis in heart failure.心力衰竭中克隆性造血的重要性。
Trends Cardiovasc Med. 2022 May;32(4):198-203. doi: 10.1016/j.tcm.2021.04.005. Epub 2021 Apr 20.
4
Evidence of Clonal Hematopoiesis and Risk of Heart Failure.克隆性造血与心力衰竭风险。
Curr Heart Fail Rep. 2020 Oct;17(5):271-276. doi: 10.1007/s11897-020-00476-w.
7
8
Clonal hematopoiesis and nonhematologic disorders.克隆性造血与非血液系统疾病。
Blood. 2020 Oct 1;136(14):1606-1614. doi: 10.1182/blood.2019000989.

引用本文的文献

1
Immunometabolism in heart failure.心力衰竭中的免疫代谢
Nat Rev Cardiol. 2025 Jun 22. doi: 10.1038/s41569-025-01165-8.
6
Inflammasomes and Atherosclerosis: a Mixed Picture.炎性小体与动脉粥样硬化:喜忧参半。
Circ Res. 2023 May 26;132(11):1505-1520. doi: 10.1161/CIRCRESAHA.123.321637. Epub 2023 May 25.
7
Clonal Hematopoiesis: Connecting Aging and Inflammation in Atherosclerosis.克隆性造血:连接动脉粥样硬化中的衰老和炎症。
Curr Atheroscler Rep. 2023 Mar;25(3):105-111. doi: 10.1007/s11883-023-01083-5. Epub 2023 Feb 18.

本文引用的文献

8
Cancer therapy shapes the fitness landscape of clonal hematopoiesis.癌症治疗改变了克隆性造血的适应性景观。
Nat Genet. 2020 Nov;52(11):1219-1226. doi: 10.1038/s41588-020-00710-0. Epub 2020 Oct 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验